Tamsulosin Hydrochloride
Product Images NDC 52959-034

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 52959-034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 Tablets Container Label (Tamsulosin HCl Capsules Container Label 100 Tablets)

TAMSULOSIN HCL 0.4 mg capsule label from H.J. Harkins Company, Inc. Shows lot number TSU00WU, manufacturer WOCKHARDT, expiration 07/12, and comparison to Flomax. Capsule identified as orange body with green cap. Label includes instructions to take as directed by doctor or see outsert for dosage information. Multiple small labels with matching information and NDC 52959-034-30 are also visible.*

FDA Label Image

Figure1 (Tamsulosin HCl Capsules Figure 1)

A line graph showing plasma concentration (ng/mL) of a substance over time (hours). Two lines represent conditions: 'Fasted' with a dashed line and 'Fed' with a solid line, illustrating differences in plasma concentration profiles between these states over a 36-hour period.*

FDA Label Image

Figure 2a (Tamsulosin HCl Capsules Figure 2a)

A line graph depicting the mean change over the duration of treatment in weeks for three groups: Tamsulosin Hydrochloride 0.8 mg, 0.4 mg, and placebo. The x-axis shows treatment duration from baseline to 13 weeks plus LOCF, and the y-axis shows mean change values. The graph illustrates changes across groups with sample sizes noted at each time point.*

FDA Label Image

Figure 2b (Tamsulosin HCl Capsules Figure 2b)

Line graph showing mean change over treatment duration in weeks comparing 0.3 mg and 0.4 mg doses of Tamsulosin Hydrochloride versus placebo. The x-axis represents duration of treatment in weeks, and the y-axis depicts mean change. The graph includes data points and sample sizes at several time points up to 13 weeks and LOCF (last observation carried forward).*

FDA Label Image

Figure3a (Tamsulosin HCl Capsules Figure 3a)

A line graph illustrating mean change in mL/sec over duration of treatment in weeks for different treatment groups: 0.8 mg, 0.4 mg, and placebo. The x-axis shows treatment duration from baseline to 13 weeks and LOCF, while the y-axis shows mean change from 0 to 3.0 mL/sec. The 0.8 mg and 0.4 mg treatments show higher mean changes compared to placebo over time.*

FDA Label Image

Figure3b (Tamsulosin HCl Capsules Figure 3b)

A line graph depicting the mean change in mL/sec over the duration of treatment in weeks for three groups: 0.8 mg dose, 0.4 mg dose, and placebo. The x-axis represents treatment duration (0 to 13 weeks plus LOCF), and the y-axis shows mean change ranging from 0 to 3 mL/sec. Sample sizes (n) are indicated below each time point.*

FDA Label Image

Structure (Tamsulosin HCl Capsules Structure)

Chemical structure diagram of Tamsulosin Hydrochloride showing its molecular components and arrangement, including aromatic rings and attached functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.